Skip to main content
. 2019 Nov 6;4(8):891–902. doi: 10.1016/j.jacbts.2019.07.002

Table 1.

Baseline Clinical Characteristics and Interleukin 5 Levels in Subjects With or Without a Major Adverse Cardiac Event or Stroke During Follow-Up

MACE
Stroke
No (n = 553) Yes (n = 143) HR (95% CI) p Value No (n = 574) Yes (n = 122) HR (95% CI) p Value
Age, yrs 65.6 ± 1.1 65.7 ± 1.2 1.13 (0.97-1.31) ns 65.6 ± 1.1 65.6 ± 1.2 1.00 (0.85-1.18) ns
Males, % 36.7 52.4 1.78 (1.29-2.45) <0.001 40.1 48.4 1.54 (1.08-2.20) ns
Current smokers, % 17.4 20.1 1.46 (0.97-2.21) ns 17.8 18.6 1.54 (0.97-2.46) ns
Diabetes, % 11.5 23.7 2.35 (1.59-3.47) <0.001 13.3 17.2 1.53 (0.94-2.48) ns
BMI, kg/m2 26.3 ± 4.0 26.7 ± 3.9 1.03 (0.99-1.07) ns 26.3 ± 4.0 26.3 ± 3.8 1.00 (0.96-1.05) ns
f-glucose, mmol/l 5.3 ± 1.4 5.6 ± 2.0 1.13 (0.97-1.31) <0.001 5.3 ± 1.4 5.6 ± 1.8 1.15 (1.04-1.28) 0.009
LDL, mmol/l 4.4 ± 1.0 4.4 ± 1.0 0.99 (0.84-1.17) ns 4.5 ± 1.0 4.2 ± 1.1 0.80 (0.66-0.98) 0.028
HDL, mmol/l 1.4 ± 0.4 1.3 ± 0.4 0.41 (0.24-0.69) 0.001 1.4 ± 0.4 1.3 ± 0.4 0.67 (0.39-1.16) ns
Triglycerides, mmol/l 1.3 (0.9-1.8) 1.3 (1.0-1.8) 1.16 (0.95-1.41) ns 1.3 (0.9-1.8) 1.3 (1.0-1.8) 1.17 (0.95-1.45) ns
Systolic BP, mm Hg 150 ± 19 155 ± 20 1.02 (1.01-1.02) <0.001 151 ± 20 152 ± 19 1.01 (1.00-1.02) ns
hsCRP, mg/l 1.6 (0.8-3.10) 1.7 (0.7-1.1) 1.04 (1.01-1.07) 0.005 1.6 (0.8-3.6) 1.5 (0.6-3.1) 1.03 (1.00-1.07) ns
Plasma IL-5, pg/ml 0.73 (0.50-1.36) 0.70 (0.47-1.14) 1.00 (1.00-1.01) ns 0.75 (0.50-1.34) 0.65 (0.47-1.26) 1.00 (1.00-1.01) ns
Leukocyte IL-5 release, pg/ml 3.8 (0-58.1) 4.6 (0-84.1) 1.00 (1.00-1.00) ns 4.40 (0-59.0) 3.1 (0-62.9) 1.00 (1.00-1.00) ns

Values are mean ± SD or median (interquartile range). Statistical comparisons between cases and controls were done using univariable Cox proportional hazards regression models.

BMI = body mass index; BP = blood pressure; CI = confidence interval; HDL = high-density lipoprotein; HR = hazard ratio; hsCRP = high-sensitivity C-reactive protein; IL = interleukin; LDL = low-density lipoprotein; MACE = major adverse cardiac event.